About us
Who We Are
ARCHIMED is a global investment firm focused on the healthcare industries. We are joining forces with scientists, healthcare professionals, entrepreneurs, and investors to positively impact companies operating in those fields. We are particularly focused on supporting them in their efforts in internationalization, capacity increase, product range expansion and acquisitions.
Our Company
Our Positioning
We are focused on small-cap and mid-cap growth buyout transactions with companies operating in one of our seven targeted sectors within healthcare.
“Our strategy is based on healthcare specialization, targeting specific segments, integrated private equity, medical and operating expertise, and a unique transatlantic platform that supports growth through internationalization.”
Denis Ribon,
Chairman – Managing Partner
Our 7 Sectors
Through our proprietary market segmentation, we split healthcare industries into prioritized sub-sectors.
Learn more
Our Investments
Through our various fund lines, we invest between 10 million and 1 billion euros in leading companies, always backing the corresponding management teams.
€10M to €1B
investment size.
Through its discretionary funds, ARCHIMED invests between 10 million and 1 billion euros in leading companies.
>400
sub-sectors.
ARCHIMED’s MedSeg is split into more than 400 sub-sectors which are individually assessed by our sector and Impact teams and consequently prioritized in terms of investment focus.
+15%
average annual growth.
Our companies’ topline is growing on average by over 15% per year.
Our Team
Global Team
Our team consists of more than 30 nationalities, mirroring the international profile of our companies and investors.
Large Diversity
We have more than 180 team members with a vast variety of backgrounds, including operational, medical, scientific and financial profiles. Half of our Investment Committee members are former CEOs from healthcare industries.
Our Global Reach
With offices in North America and Europe, and with investments also completed across APAC and LATAM, we provide a global reach for our companies and investors.
Our Impact
Creating Value for Our Companies
We help companies to get better at what they already do in order to build sustainable leaders beyond ARCHIMED’s exit horizon. We hold a strong sense of commitment to our partnering companies.
+60%
on average.
ARCHIMED is accelerating companies growth rate by more than 60% compared to pre-ARCHIMED performance.
Creating Value for Our Investors
We provide superior returns to our Fund investors thanks to our focus on some of the most attractive sectors and companies within the healthcare industries.
10%
Top decile perfomers.
All ARCHIMED funds are at least top decile performers compared to all other buyout funds at the global level.
Creating Value for Society
We embed sustainability at all levels. We select the most impactful companies and support the growth of a responsible and sustainable portfolio, through our robust impact investment strategy. All our funds are at the most demanding sustainability levels for their corresponding vintages, ie. either Article 8 or Article 9 of the European Sustainable Finance Disclosure Regulation (SFDR).
100%
All ARCHIMED Funds
are classified under SFDR Article 8 or 9.
Our EURÊKA Foundation
The EURÊKA Foundation was created at the same time as ARCHIMED. It is supported both financially and through the volunteering actions of our teams.
5%
of ARCHIMED’s profit
from carried interest is returned to the community through the EURÊKA Foundation.